Citations (40)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Pietro Scicchitano, Francesca Cortese, Gabriella Ricci, Santa Carbonara, Michele Moncelli, Massimo Iacoviello, Annagrazia Cecere, Michele Gesualdo, Annapaola Zito, Pasquale Caldarola, Domenico Scrutinio, Rocco Lagioia, Graziano Riccioni & Marco Matteo Ciccone. (2014) Ivabradine, coronary artery disease, and heart failure: beyond rhythm control. Drug Design, Development and Therapy 8, pages 689-700.
Read now
Read now
Adonis Saremi, Dipika Gopal & Alan S Maisel. (2012) Brain natriuretic peptide-guided therapy in the inpatient management of decompensated heart failure. Expert Review of Cardiovascular Therapy 10:2, pages 191-203.
Read now
Read now
Henrik Vase, Thomas Guldager Lauridsen, Jesper Nørgaard Bech & Erling Bjerregaard Pedersen. (2009) Effects of dihydralazine on renal water and aquaporin‐2 excretion in humans. Scandinavian Journal of Clinical and Laboratory Investigation 69:1, pages 45-51.
Read now
Read now
Articles from other publishers (37)
Livija Sušić, Lana Maričić, Ines Šahinović, Kristina Kralik, Lucija Klobučar, Mateja Ćosić, Tihomir Sušić, Josip Vincelj, Antonio Burić, Marko Burić & Matea Lukić. (2023) The Relationship of Left Ventricular Diastolic Dysfunction and Asymmetrical Dimethylarginine as a Biomarker of Endothelial Dysfunction with Cardiovascular Risk Assessed by Systematic Coronary Risk Evaluation2 Algorithm and Heart Failure—A Cross-Sectional Study. International Journal of Environmental Research and Public Health 20:5, pages 4433.
Crossref
Crossref
Katharine A. Kott, Michael Bishop, Christina H. J. Yang, Toby M. Plasto, Daniel C. Cheng, Adam I. Kaplan, Louise Cullen, David S. Celermajer, Peter J. Meikle, Stephen T. Vernon & Gemma A. Figtree. (2022) Biomarker Development in Cardiology: Reviewing the Past to Inform the Future. Cells 11:3, pages 588.
Crossref
Crossref
Yusuke Tamamura, Michiko Matsuura, Sumiko Shiba & Toshio Nishikimi. (2021) Effect of heart failure and malnutrition, alone and in combination, on rehabilitation effectiveness in patients with hip fracture. Clinical Nutrition ESPEN 44, pages 356-366.
Crossref
Crossref
Yusuke Tamamura, Micihko Matsuura, Sumiko Shiba & Toshio Nishikimi. (2020) Heart failure assessed based on plasma B-type natriuretic peptide (BNP) levels negatively impacts activity of daily living in patients with hip fracture. PLOS ONE 15:8, pages e0237387.
Crossref
Crossref
Adrien Grandjean, Pierre-Yves Courand, Carine Mouly-Bertin, Constance Berge, Fatou Langevin, Brahim Harbaoui, Damien Garcia & Pierre Lantelme. (2020) Risk stratification in hypertension. Journal of Hypertension 38:1, pages 65-72.
Crossref
Crossref
Hiroyuki Tsutsui, Shin-ichi Momomura, Akira Yamashina, Hiroaki Shimokawa, Yasuki Kihara, Yoshihiko Saito, Nobuhisa Hagiwara, Hiroshi Ito, Masafumi Yano, Kazuhiro Yamamoto, Junya Ako, Takayuki Inomata, Yasushi Sakata, Takashi TanakaYasushi Kawasaki. (2019) Efficacy and Safety of Ivabradine in Japanese Patients With Chronic Heart Failure ― J-SHIFT Study ―. Circulation Journal 83:10, pages 2049-2060.
Crossref
Crossref
Domingo A. Pascual-Figal. (2017) Neprilysin and Heart Failure. Journal of the American College of Cardiology 70:17, pages 2154-2156.
Crossref
Crossref
C.J. Pemberton, C.J. Charles & A.M. Richards. 2017. Endocrinology of the Heart in Health and Disease. Endocrinology of the Heart in Health and Disease
3
39
.
Ovidiu Chioncel, Sean P. Collins, Stephen J. Greene, Andrew P. Ambrosy, Muthiah Vaduganathan, Cezar Macarie, Javed Butler & Mihai Gheorghiade. (2016) Natriuretic peptide-guided management in heart failure. Journal of Cardiovascular Medicine 17:8, pages 556-568.
Crossref
Crossref
Kenneth Verboven, Dominique Hansen, Cedric Moro, Bert O. Eijnde, Nicole Hoebers, Joep Knol, Wim Bouckaert, Anne Dams, Ellen E. Blaak & Johan W.E. Jocken. (2016) Attenuated atrial natriuretic peptide-mediated lipolysis in subcutaneous adipocytes of obese type 2 diabetic men. Clinical Science 130:13, pages 1105-1114.
Crossref
Crossref
A. Mark Richards. (2015) Natriuretic Peptide Goal-Directed Therapy: Are We There Yet?. Current Emergency and Hospital Medicine Reports 3:2, pages 80-88.
Crossref
Crossref
Andrew C. Don-Wauchope & Robert S. McKelvie. (2015) Evidence based application of BNP/NT-proBNP testing in heart failure. Clinical Biochemistry 48:4-5, pages 236-246.
Crossref
Crossref
Wei Xin, Zhiqin Lin & Shuhua Mi. (2014) Does B-type natriuretic peptide-guided therapy improve outcomes in patients with chronic heart failure? A systematic review and meta-analysis of randomized controlled trials. Heart Failure Reviews 20:1, pages 69-80.
Crossref
Crossref
R. W. Troughton, C. M. Frampton, H.-P. Brunner-La Rocca, M. Pfisterer, L. W. M. Eurlings, H. Erntell, H. Persson, C. M. O'Connor, D. Moertl, P. Karlstrom, U. Dahlstrom, H. K. Gaggin, J. L. Januzzi, R. Berger, A. M. Richards, Y. M. Pinto & M. G. Nicholls. (2014) Effect of B-type natriuretic peptide-guided treatment of chronic heart failure on total mortality and hospitalization: an individual patient meta-analysis. European Heart Journal 35:23, pages 1559-1567.
Crossref
Crossref
Pierre-Yves Courand, Nathalie Gaudebout, Carine Mouly-Bertin, Vivien Thomson, Jean-Pierre Fauvel, Giampiero Bricca & Pierre Lantelme. (2013) Biological, electrical and echocardiographic indices versus cardiac magnetic resonance imaging in diagnosing left ventricular hypertrophy. Hypertension Research 37:5, pages 444-451.
Crossref
Crossref
Luis Sargento, Milan Satendra, Susana Longo, Nuno Lousada & Roberto Palma dos Reis. (2013)
Early
NT‐proBNP
Decrease With Ivabradine in Ambulatory Patients With Systolic Heart Failure
. Clinical Cardiology 36:11, pages 677-682.
Crossref
Crossref
Hua Cui, Guoliang Huo, Lin Liu, Li Fan, Ping Ye, Jian Cao, Yongyi Bai, Fan Wang & Yixin Hu. (2012) Association of cardiac and renal function with extreme N-terminal fragment Pro-B-type natriuretic peptide levels in elderly patients. BMC Cardiovascular Disorders 12:1.
Crossref
Crossref
Dermot Phelan, Chris Watson, Ramon Martos, Patrick Collier, Anil Patle, Seamas Donnelly, Mark Ledwidge, John Baugh & Ken McDonald. (2012) Modest Elevation in BNP in Asymptomatic Hypertensive Patients Reflects Sub-Clinical Cardiac Remodeling, Inflammation and Extracellular Matrix Changes. PLoS ONE 7:11, pages e49259.
Crossref
Crossref
Benedetta DeBeradinis & James L. Januzzi. (2012) Use of biomarkers to guide outpatient therapy of heart failure. Current Opinion in Cardiology 27:6, pages 661-668.
Crossref
Crossref
A Mark Richards & Richard W Troughton. (2012) Use of Natriuretic Peptides to Guide and Monitor Heart Failure Therapy. Clinical Chemistry 58:1, pages 62-71.
Crossref
Crossref
Richard W. Troughton & M. Gary Nicholls. (2014) B‐type natriuretic peptide or amino‐terminal pro‐B‐type natriuretic peptide‐guided treatment of heart failure: what is the next STEP?. European Journal of Heart Failure 13:10, pages 1046-1048.
Crossref
Crossref
A. Mark Richards. (2011) Tailored therapy for heart failure: neurohormones. Canadian Journal of Physiology and Pharmacology 89:8, pages 603-607.
Crossref
Crossref
Giampiero Bricca & Pierre Lantelme. (2011) Natriuretic peptides: Ready for prime-time in hypertension?. Archives of Cardiovascular Diseases 104:6-7, pages 403-409.
Crossref
Crossref
Nicholas B Norgard & Gina M Prescott. (2011) Future of personalized pharmacotherapy in chronic heart failure patients. Future Cardiology 7:3, pages 357-379.
Crossref
Crossref
F. Del Greco M.C. Pattaro, A. Luchner, I. Pichler, T. Winkler, A. A. Hicks, C. Fuchsberger, A. Franke, S. A. Melville, A. Peters, H. E. Wichmann, S. Schreiber, I. M. Heid, M. Krawczak, C. Minelli, C. J. Wiedermann & P. P. Pramstaller. (2011) Genome-wide association analysis and fine mapping of NT-proBNP level provide novel insight into the role of the MTHFR-CLCN6-NPPA-NPPB gene cluster. Human Molecular Genetics 20:8, pages 1660-1671.
Crossref
Crossref
V. Paget, L. Legedz, N. Gaudebout, N. Girerd, G. Bricca, H. Milon, M. Vincent & P. Lantelme. (2011) N-Terminal Pro-Brain Natriuretic Peptide: A Powerful Predictor of Mortality in Hypertension. Hypertension 57:4, pages 702-709.
Crossref
Crossref
C. Ceconi, S.B. Freedman, J.C. Tardif, P. Hildebrandt, T. McDonagh, P. Gueret, G. Parrinello, M. Robertson, P.G. Steg, M. Tendera, I. Ford, K. Fox & R. Ferrari. (2011) Effect of heart rate reduction by ivabradine on left ventricular remodeling in the echocardiographic substudy of BEAUTIFUL. International Journal of Cardiology 146:3, pages 408-414.
Crossref
Crossref
Søren Astrup JensenPhilip HasbakJann MortensenJens Benn Sørensen. (2010) Fluorouracil Induces Myocardial Ischemia With Increases of Plasma Brain Natriuretic Peptide and Lactic Acid but Without Dysfunction of Left Ventricle. Journal of Clinical Oncology 28:36, pages 5280-5286.
Crossref
Crossref
Bert Vaes, Victoria Delgado, Jeroen Bax, Jan Degryse, Rudi GJ Westendorp & Jacobijn Gussekloo. (2010) Diagnostic accuracy of plasma NT-proBNP levels for excluding cardiac abnormalities in the very elderly. BMC Geriatrics 10:1.
Crossref
Crossref
Richard W. Troughton, Chris M. Frampton & M. Gary Nicholls. (2010) Biomarker-Guided Treatment of Heart Failure. Journal of the American College of Cardiology 56:25, pages 2101-2104.
Crossref
Crossref
Per Hildebrandt, Paul O. Collinson, Robert N. Doughty, Ahmet Fuat, David C. Gaze, Finn Gustafsson, James Januzzi, Jens Rosenberg, Roxy Senior & Mark Richards. (2010) Age-dependent values of N-terminal pro-B-type natriuretic peptide are superior to a single cut-point for ruling out suspected systolic dysfunction in primary care?. European Heart Journal 31:15, pages 1881-1889.
Crossref
Crossref
Yang Xue, Jeffrey Chan, Sonal Sakariya & Alan Maisel. (2010) Biomarker-Guided Treatment of Congestive Heart Failure. Congestive Heart Failure 16, pages S62-S67.
Crossref
Crossref
John G. Lainchbury, Richard W. Troughton, Kim M. Strangman, Christopher M. Frampton, Anna Pilbrow, Timothy G. Yandle, Amjad K. Hamid, M. Gary Nicholls & A. Mark Richards. (2009) N-Terminal Pro–B-Type Natriuretic Peptide-Guided Treatment for Chronic Heart Failure. Journal of the American College of Cardiology 55:1, pages 53-60.
Crossref
Crossref
John K. Kjekshus, Christian Torp‐Pedersen, Lars Gullestad, Lars Køber, Thor Edvardsen, Inge C. Olsen, Ivar Sjaastad, Eirik Qvigstad, Tor Skomedal, Jan‐Bjørn Osnes & Finn Olav Levy. (2009)
Effect of piboserod, a 5‐HT
4
serotonin receptor antagonist, on left ventricular function in patients with symptomatic heart failure
. European Journal of Heart Failure 11:8, pages 771-778.
Crossref
Crossref
Bert Vaes, Wouter De Ruijter, Jan Degryse, Rudi G. J. Westendorp & Jacobijn Gussekloo. (2009) Clinical Relevance of a Raised Plasma N-Terminal Pro-Brain Natriuretic Peptide Level in a Population-Based Cohort of Nonagenarians. Journal of the American Geriatrics Society 57:5, pages 823-829.
Crossref
Crossref
Philippe Camus, Clio Camus & Pascal Foucher. 2009. Integrated Cardiothoracic Imaging with MDCT. Integrated Cardiothoracic Imaging with MDCT
131
157
.
Patrick J. Gallegos, Eric J. MacLaughlin & Krystal K. Haase. (2012) Serial Monitoring of Brain Natriuretic Peptide Concentrations for Drug Therapy Management in Patients with Chronic Heart Failure. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 28:3, pages 343-355.
Crossref
Crossref